Ilevro and Itching - a phase IV clinical study of FDA data

Summary:

Itching is reported as a side effect among people who take Ilevro (nepafenac), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin D3, and have Asthma.

The phase IV clinical study analyzes which people have Itching when taking Ilevro. It is created by eHealthMe based on reports of 1,529 people who have side effects when taking Ilevro from the FDA, and is updated regularly.

What is Ilevro?

Ilevro has active ingredients of nepafenac. eHealthMe is studying from 1,531 Ilevro users. Check the latest studies of Ilevro.

What is Itching?

Itching is found to be associated with 3,210 drugs and 4,534 conditions by eHealthMe. Check the latest studies of Itching.

On Jul, 16, 2026

1,529 people reported to have side effects when taking Ilevro.
Among them, 26 people (1.7%) have Itching.

Among these 26 people:

How long have people been on Ilevro when they have Itching? *

What is the gender of people who have Itching when taking Ilevro? *

female: 60.87 %
male: 39.13 %

What is the age of people who have Itching when taking Ilevro? *

What are other drugs people take besides Ilevro? *

Durezol: 7 people, 26.92%
Vitamin D3: 7 people, 26.92%
Zolpidem Tartrate: 5 people, 19.23%
Levofloxacin: 5 people, 19.23%
Keflex: 5 people, 19.23%
Hydrocodone: 5 people, 19.23%
Furosemide: 5 people, 19.23%
Fluticasone Propionate: 5 people, 19.23%
Fasenra: 5 people, 19.23%
Epinephrine: 5 people, 19.23%

What are other side effects people have besides Itching? *

Fatigue (feeling of tiredness): 8 people, 30.77%
Headache (pain in head): 7 people, 26.92%
Dyspnea (difficult or laboured breathing): 6 people, 23.08%
Urticaria (rash of round, red welts on the skin that itch intensely): 6 people, 23.08%
Fever: 6 people, 23.08%
Asthma: 5 people, 19.23%
Sinus Congestion (blockage of sinus): 5 people, 19.23%
Chills (felling of cold): 5 people, 19.23%
Infusion Related Reaction: 5 people, 19.23%
Weakness: 5 people, 19.23%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 5 people, 19.23%
Asthma: 5 people, 19.23%
Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 11.54%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 3 people, 11.54%
Cataract (clouding of the lens inside the eye): 3 people, 11.54%
Stress And Anxiety: 1 person, 3.85%
Seasonal Allergy (allergic condition due to certain season): 1 person, 3.85%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 3.85%
Intraocular Pressure Increased: 1 person, 3.85%
High Blood Pressure: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Ilevro and have Itching?

- Check whether Itching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ilevro:

Ilevro (1,531 reports)

Itching treatments and more:

Itching (398,821 reports)

Browse all side effects of Ilevro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Itching:

Itching (3,210 drugs)

Browse all the conditions that are associated with Itching:

Itching (4,534 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nepafenac (the active ingredients of Ilevro) and Ilevro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.